- Home
- CAAP vs LGND Comparison
CAAP vs LGND Comparison
Compare CAAP & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- LGND
- Stock Information
- Founded
- CAAP 1998
- LGND 1987
- Country
- CAAP Luxembourg
- LGND United States
- Employees
- CAAP N/A
- LGND N/A
- Industry
- CAAP Aerospace
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- CAAP Consumer Discretionary
- LGND Health Care
- Exchange
- CAAP Nasdaq
- LGND Nasdaq
- Market Cap
- CAAP 2.4B
- LGND 2.0B
- IPO Year
- CAAP 2018
- LGND 1992
- Fundamental
- Price
- CAAP $18.78
- LGND $119.19
- Analyst Decision
- CAAP Strong Buy
- LGND Strong Buy
- Analyst Count
- CAAP 1
- LGND 6
- Target Price
- CAAP $21.50
- LGND $144.83
- AVG Volume (30 Days)
- CAAP 179.8K
- LGND 143.5K
- Earning Date
- CAAP 11-20-2024
- LGND 11-07-2024
- Dividend Yield
- CAAP N/A
- LGND N/A
- EPS Growth
- CAAP 114.63
- LGND 160.46
- EPS
- CAAP 2.22
- LGND 2.47
- Revenue
- CAAP $1,471,077,000.00
- LGND $152,422,000.00
- Revenue This Year
- CAAP $27.07
- LGND $23.19
- Revenue Next Year
- CAAP $19.62
- LGND $15.08
- P/E Ratio
- CAAP $8.43
- LGND $48.22
- Revenue Growth
- CAAP N/A
- LGND N/A
- 52 Week Low
- CAAP $12.70
- LGND $57.00
- 52 Week High
- CAAP $19.98
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- CAAP 50.74
- LGND 57.87
- Support Level
- CAAP $17.67
- LGND $109.53
- Resistance Level
- CAAP $19.98
- LGND $125.76
- Average True Range (ATR)
- CAAP 0.78
- LGND 5.74
- MACD
- CAAP -0.10
- LGND -0.56
- Stochastic Oscillator
- CAAP 47.84
- LGND 50.39
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.